Intervention strategies to prevent pathogenetic effects of glycated albumin
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 419 (1) , 25-30
- https://doi.org/10.1016/j.abb.2003.08.012
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- ERK Mediates Effects of Glycated Albumin in Mesangial CellsBiochemical and Biophysical Research Communications, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Glycated Albumin Stimulates Fibronectin and Collagen IV Production by Glomerular Endothelial Cells under Normoglycemic ConditionsBiochemical and Biophysical Research Communications, 1997
- Glycated Albumin Promotes a Generalized Vasculopathy in thedb/dbMouseBiochemical and Biophysical Research Communications, 1996
- Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcriptionMolecular and Cellular Biochemistry, 1995
- PRODUCTION OF PSEUDODIABETIC RENAL GLOMERULAR CHANGES IN MICE AFTER REPEATED INJECTIONS OF GLUCOSYLATED PROTEINSThe Lancet, 1980
- Hyperinsulinemia in pre-weaning diabetes (db) miceDiabetologia, 1974
- Studies in the diabetic mutant mouse: III. Physiological factors associated with alterations in beta cell proliferationDiabetologia, 1970
- Published by Oxford University Press (OUP)